2306
F.-R. Alexandre, F. Huet / Tetrahedron: Asymmetry 9 (1998) 2301–2310
3.4. (−)-3-Methoxy-2-(hydroxymethyl)propylacetate 11; (S)-3-(tert-butoxy)-2-(hydroxymethyl)propyl-
acetate 12; (R)-3-hydroxy-2-[(phenylsulfanyl)methyl]propylacetate 13; 3-(tert-butoxy)-2-(hydroxymethyl)-
2-ethylpropylacetate 14
Compound (−)-11 was obtained by stirring 2-(methoxymethyl)propan-1,3-diol (149 mg, 1.24 mmol)
and PFL (15 mg) in vinyl acetate (3 ml) for 24 h, at room temperature. Enzyme was then removed
by filtration on a sintered-glass funnel. Washing (vinyl acetate), evaporation and flash chromatography
20
D
on silica gel (cyclohexane:AcOEt=1:1) provided (−)-11 (30 mg, 15%, 79% ee, [α] − 1.47 (CHCl3,
c=1.7)) as a colorless oil. Diacetate could also be isolated. Compound (S)-12 was obtained in the same
way from diol 6 (517 mg, 3.2 mmol), PFL (83 mg), vinyl acetate (10 ml), in 2 h. It was obtained as a
20
D
colorless oil (640 mg, 97%, 91% ee, [α] +1.8 (CHCl3, c=4.0)). In another experiment PFL was replaced
by PPL. Compound (S)-12 was thus obtained in 52% yield and 38% ee. Compound (R)-13 was obtained
by a similar procedure to (−)-11, in 3 h at 7°C, starting from diol 7 (105 mg, 0.53 mmol) and PFL
(10 mg) in vinyl acetate (5 ml). Flash chromatography (cyclohexane:AcOEt=6:4) provided (R)-13 as
20
D
a colorless oil (97 mg, 76%, 88% ee, [α] +14.7 (CHCl3, c=7.4)). Compound 14 was obtained by a
similar procedure as for (−)-11, in 3–7 days, starting from diol 8 (80 mg, 0.45 mmol) and PFL (15 mg)
in vinyl acetate (2 ml). Flash chromatography (cyclohexane:AcOEt=8:2) provided 14 as a colorless oil
20
(13 mg, 13%, 11% ee, [α] was very low and could not be measured).
D
1
Data for 11: H NMR δ 2.07 (s, 3H), 2.14 (m, 1H), 2.58 (br s, 1H, OH), 3.35 (s, 3H), 3.48 (dd, 1H,
J=9.3, 6.0 Hz), 3.53 (dd, 1H, J=9.3, 5.4 Hz), 3.71 (d, 2H, J=5.1 Hz), 4.18 (d, 2H, J=6.0 Hz); 13C NMR
δ 20.8 (CH3), 40.7 (CH), 59.1 (CH3), 62.2 (CH2), 62.5 (CH2), 72.4 (CH2), 171.3 (CO); IR (film): 3448,
2898, 1741, 1247, 1108, 1039 cm−1; GPC/MS (EI) m/z (rel. int.) 163 (MH+, <0.5), 145 (2), 131 (1), 84
(6), 71 (29), 61 (20), 57 (18), 45 (56), 43 (100); anal. calcd for C7H14O4+0.05H2O: C, 51.58; H, 8.65,
found: C, 51.39; H, 8.69.
1
Data for 12: H NMR δ 1.20 (s, 9H), 2.07 (s, 3H), 2.07 (m, 1H), 2.95 (m, 1H, OH), 3.49 (dd, 1H,
J=8.8, 5.9 Hz), 3.57 (dd, 1H, J=8.8, 4.7 Hz), 3.74 (m, 2H), 4.17 (d, 2H, J=6.5 Hz); 13C NMR δ 20.9
(CH3), 27.3 (3C, CH3), 40.5 (CH), 62.3 (CH2), 62.8 (CH2), 63.4 (CH2), 73.5 (quat. C), 171.2 (CO);
IR (film): 3453, 2973, 1741, 1243, 1039 cm−1; GPC/MS m/z (rel. int.) 205 (MH+, <0.5), 149 (39), 131
(100), 87 (16), 59 (27), 57 (27), 43 (90); anal. calcd for C10H20O4+0.2H2O: C, 57.73; H, 9.81, found: C,
57.79; H, 9.97.
Data for 13: 1H NMR δ 2.06 (s, 3H), 2.09 (m, 2H, OH and H-2), 2.96 (dd, 1H, J=13.5, 6.9 Hz), 3.02
(dd, 1H, J=13.5, 7.0 Hz), 3.69 (m, 2H), 4.24 (d, 2H, J=5.6 Hz), 7.18 (m, 1H), 7.28 (m, 2H), 7.36 (m,
2H); 13C NMR δ 20.8 (CH3), 32.3 (CH2), 40.3 (CH), 61.7 (CH2), 63.5 (CH2), 126.3 (CH), 129.0 (2C,
CH), 129.4 (2C, CH), 135.9 (quat. C), 171.4 (CO); IR (film): 3442, 3056, 2952, 2892, 1733, 1481, 1438,
1243, 1039, 740, 692 cm−1; HPLC/MS (EI) m/z (rel. int.) 240 (M+, 39), 149 (63), 131 (17), 123 (45),
110 (100), 109 (43); anal. calcd for C12H16O3S: C, 59.98; H, 6.71; S, 13.34, found: C, 59.62; H, 6.83; S,
12.98.
Data for 14: 1H NMR δ 0.85 (s, 3H), 1.18 (s, 9H), 2.08 (s, 3H), 3.24 (m, 1H, OH), 3.31 (d, 1H, J=8.7
Hz), 3.38 (d, 1H, J=8.7 Hz), 3.54 (m, 2H), 4.09 (d, 1H, J=11.0 Hz), 4.14 (d, 1H, J=11.0 Hz); 13C NMR
(CDCl3) δ 17.3 (CH3), 20.8 (CH3), 27.2 (3C, CH3), 39.1 (quat. C), 66.6 (CH2), 67.5 (CH2), 68.5(CH2),
73.4 (quat. C), 171.2 (CO); IR (film): 3455, 2973, 1733, 1365, 1243, 1199, 1085, 1039 cm−1
.
3.5. 3-(Acetyloxy)-2-(tert-butoxymethyl)propylacetate 15
This compound was obtained together with (ꢀ)-12 which was prepared to measure the ee of (S)-12.
Preparation of 15 was not optimised. Diol 6 (4.219 g, 26 mmol), Ac2O (2.5 ml, 26 mmol) and pyridine